Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriaki Hirayama

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Pharmacokinetics|December 15, 2016
Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicityNoriaki Hirayama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2007
[Docking method for drug discovery]Noriaki Hirayama
International Journal of Medicinal Chemistry|November 29, 2014
A possible molecular mechanism of immunomodulatory activity of bilirubinHideto Isogai, Noriaki Hirayama
ISRN Pharmaceutics|March 28, 2013
In Silico Prediction of Interactions between Site II on Human Serum Albumin and Profen DrugsHideto Isogai, Noriaki Hirayama
Journal of Computational Chemistry|March 27, 2010
Alpha sphere filter method: Application of pseudomolecular descriptors in virtual screening of 2D chemical structuresHajime Muta, Noriaki Hirayama
Topics in Current Chemistry|April 23, 2013
Molecular Mechanisms of Dielectrically Controlled Resolution (DCR)Kenichi Sakai, Rumiko Sakurai, Noriaki Hirayama
Journal of Medicinal Chemistry|December 24, 2004
Ph4Dock: pharmacophore-based protein-ligand dockingJunichi Goto, Ryoichi Kataoka, Noriaki Hirayama
Chemical & Pharmaceutical Bulletin|October 6, 2005
Prediction of solvents suitable for crystallization of small organic moleculesKozo Hosokawa, Junichi Goto, Noriaki Hirayama
Journal of Biochemistry|August 3, 2002
Interactions of arsenic with human metallothionein-2Mitsutoshi Toyama, Mitsuo Yamashita, Noriaki Hirayama, et al.
Current Genomics|July 23, 2008
Megsin gene: its genomic analysis, pathobiological functions, and therapeutic perspectivesToshio Miyata, Ming Li, Xueqing Yu, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Pharmacokinetics|December 15, 2016
Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicityNoriaki Hirayama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2007
[Docking method for drug discovery]Noriaki Hirayama
International Journal of Medicinal Chemistry|November 29, 2014
A possible molecular mechanism of immunomodulatory activity of bilirubinHideto Isogai, Noriaki Hirayama
ISRN Pharmaceutics|March 28, 2013
In Silico Prediction of Interactions between Site II on Human Serum Albumin and Profen DrugsHideto Isogai, Noriaki Hirayama
Journal of Computational Chemistry|March 27, 2010
Alpha sphere filter method: Application of pseudomolecular descriptors in virtual screening of 2D chemical structuresHajime Muta, Noriaki Hirayama
Topics in Current Chemistry|April 23, 2013
Molecular Mechanisms of Dielectrically Controlled Resolution (DCR)Kenichi Sakai, Rumiko Sakurai, Noriaki Hirayama
Journal of Medicinal Chemistry|December 24, 2004
Ph4Dock: pharmacophore-based protein-ligand dockingJunichi Goto, Ryoichi Kataoka, Noriaki Hirayama
Chemical & Pharmaceutical Bulletin|October 6, 2005
Prediction of solvents suitable for crystallization of small organic moleculesKozo Hosokawa, Junichi Goto, Noriaki Hirayama
Journal of Biochemistry|August 3, 2002
Interactions of arsenic with human metallothionein-2Mitsutoshi Toyama, Mitsuo Yamashita, Noriaki Hirayama, et al.
Current Genomics|July 23, 2008
Megsin gene: its genomic analysis, pathobiological functions, and therapeutic perspectivesToshio Miyata, Ming Li, Xueqing Yu, et al.
Pageof 5